Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

852 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer.
Fukuda M, Oka M, Soda H, Kinoshita A, Fukuda M, Nagashima S, Kuba M, Takatani H, Tsurutani J, Nakamura Y, Kasai T, Inoue Y, Soejima Y, Kohno S; Nagasaki Thoracic Oncology Group. Fukuda M, et al. Among authors: kinoshita a. Cancer Chemother Pharmacol. 2004 Dec;54(6):573-7. doi: 10.1007/s00280-004-0805-2. Epub 2004 Sep 10. Cancer Chemother Pharmacol. 2004. PMID: 15365766 Clinical Trial.
Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer.
Tomonaga N, Nakamura Y, Soda H, Nagashima S, Nakano H, Kinoshita A, Fukuda M, Fukuda M, Takatani H, Soejima Y, Oka M, Kohno S; Nagasaki Thoracic Oncology Group. Tomonaga N, et al. Among authors: kinoshita a. Cancer Chemother Pharmacol. 2008 Jun;62(1):43-9. doi: 10.1007/s00280-007-0571-z. Epub 2007 Aug 24. Cancer Chemother Pharmacol. 2008. PMID: 17717667 Clinical Trial.
A phase I study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer.
Fukuda M, Nakamura Y, Kasai T, Nagashima S, Nakatomi K, Doi S, Nakano H, Takatani H, Fukuda M, Kinoshita A, Soda H, Tsukamoto K, Oka M, Kohno S; Nagasaki Thoracic Oncology Group. Fukuda M, et al. Among authors: kinoshita a. J Thorac Oncol. 2009 Jun;4(6):741-5. doi: 10.1097/JTO.0b013e3181a52946. J Thorac Oncol. 2009. PMID: 19404211 Free article. Clinical Trial.
Randomized phase II trial of irinotecan with paclitaxel or gemcitabine for non-small cell lung cancer: association of UGT1A1*6 and UGT1A1*27 with severe neutropenia.
Nakamura Y, Soda H, Oka M, Kinoshita A, Fukuda M, Fukuda M, Takatani H, Nagashima S, Soejima Y, Kasai T, Nakatomi K, Masuda N, Tsukamoto K, Kohno S. Nakamura Y, et al. Among authors: kinoshita a. J Thorac Oncol. 2011 Jan;6(1):121-7. doi: 10.1097/JTO.0b013e318200e4e8. J Thorac Oncol. 2011. PMID: 21150467 Free article. Clinical Trial.
Phase I and II trials of vinorelbine with carboplatin for patients 75 years of age or older with previously untreated non-small-cell lung cancer.
Takatani H, Nakamura Y, Nagashima S, Soda H, Kinoshita A, Fukuda M, Fukuda M, Soejima Y, Kasai T, Nakatomi K, Iida T, Oka M, Tsukamoto K, Kohno S. Takatani H, et al. Among authors: kinoshita a. Clin Lung Cancer. 2012 Sep;13(5):347-51. doi: 10.1016/j.cllc.2011.11.007. Epub 2012 Jan 20. Clin Lung Cancer. 2012. PMID: 22264660 Clinical Trial.
Phase II study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small cell lung cancer.
Fukuda M, Nakamura Y, Kinoshita A, Soejima Y, Yamaguchi H, Ikeda T, Izumikawa K, Takatani H, Fukuda M, Soda H, Hayashi N, Tsukamoto K, Oka M, Kohno S. Fukuda M, et al. Among authors: kinoshita a. Cancer Chemother Pharmacol. 2012 Nov;70(5):645-51. doi: 10.1007/s00280-012-1952-5. Epub 2012 Aug 22. Cancer Chemother Pharmacol. 2012. PMID: 23010852 Clinical Trial.
852 results